FDA DEVICE FACTS
AncestryDNA Factor V Leiden Genetic Health Risk Test
Ancestry Genomics, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The AncestryDNA Factor V Leiden Genetic Health Risk Test for Hereditary Thrombophilia uses qualitative genotyping to detect clinically relevant variants in genomic DNA isolated from human saliva collected from individuals 18 years and older with the AncestryDNA Saliva Collection Kit for the purpose of reporting and interpreting Genetic Health Risks (GHR).
The AncestryDNA Factor V Leiden Genetic Health Risk Report for Hereditary Thrombophilia is indicated for reporting of the Factor V Leiden variant in the F5 gene. This report describes if a person has variants associated with a higher risk of developing harmful blood clots, but it does not describe a person's overall risk of developing harmful blood clots. This test is most relevant for people of European descent.
a. For over-the-counter (OTC) use. b. This test is not a substitute for visits to a healthcare provider. It is recommended that you consult with a healthcare provider if you have any questions or concerns about your results. c. The AncestryDNA Factor V Leiden Genetic Health Risk (GHR) Test does not detect all genetic variants associated with Hereditary Thrombophilia. The absence of a variant tested does not rule out the presence of other genetic variants that may be disease-related. d. The test is intended for users ≥ 18 years old. e. The test does not diagnose any specific health conditions. Results should not be used to make medical decisions. f. The laboratory may not be able to process a user’s sample. The probability that the laboratory cannot process a sample can be up to 3% (This estimate was obtained from samples processed in one lab only). If this happens, we will notify you by e-mail and you may request one free replacement kit to provide us with a new sample.
Ancestry Genomics, Inc. July 17, 2020 AncestryDNA Factor V Leiden Genetic Health Risk Test AINN Response
CONFIDENTIAL Page 5-3 g. A user’s race, ethnicity, age, and other lifestyle factors may affect how the genetic test results are interpreted. h. Subject to meeting the limitations contained in the special controls under regulation 21 CFR 866.5950.
The AncestryDNA Factor V Leiden Genetic Health Risk Test is to be performed using the Tecan Evo and Illumina iScan instruments.
GenomeStudio Software is a modular software application that is used to view and analyze genotypic data obtained from the Illumina iScan System and based on the cluster definition file. AncestryDNA GHR software conducts a variety of control checks on the file, resulting in a final genotype profile for each sample. These data are used to generate test reports on a user’s genotype and associated risk of disease.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。